English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Apr 29, 2026
PhRMA questions hospital use of 340B revenues after Minnesota reporting data shows $1.3B in earnings
Patient Daily
| Apr 29, 2026
USC Schaeffer Center's Sood on PBMs: 'If PBMs want to claim they save employers and patients billions, they should be willing to prove it'
Patient Daily
| Apr 28, 2026
Archo Advocacy CEO Toresco on PBMs: 'PBMs profit from keeping prices high. Patients pay the spread'
Patient Daily
| Apr 24, 2026
Steve Forbes on 340B program: Hospitals use it ‘to divert taxpayer-subsidized benefits for patients to unrelated interests’
Patient Daily
| Apr 16, 2026
Health Analyst: Abuse of 340b drug discount program ‘leaves patients stuck in the middle’
Patient Daily
| Apr 10, 2026
Heartland Institute's Milloy on vaccine liability: 'Simply ending immunity on vaccines will only make things worse'
Patient Daily
| Apr 10, 2026
Cornell Health Policy Center survey: 78% of experts say weakening vaccine liability protections would curb innovation
Patient Daily
| Apr 9, 2026
Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
Trending
+
Regulatory
Patient Daily
| Apr 28, 2026
Archo Advocacy CEO Toresco on PBMs: 'PBMs profit from keeping prices high. Patients pay the spread'
+
Pharmaceuticals
Patient Daily
| Apr 24, 2026
Washington Post Opinion Editor on 340B drug discounts: 'The program has become a profit-making venture for big businesses'
+
Regulatory
Patient Daily
| Apr 29, 2026
USC Schaeffer Center's Sood on PBMs: 'If PBMs want to claim they save employers and patients billions, they should be willing to prove it'
+
Regulatory
Patient Daily
| Apr 24, 2026
Steve Forbes on 340B program: Hospitals use it ‘to divert taxpayer-subsidized benefits for patients to unrelated interests’
1
2
»
Last »
